NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹50 Cr | ₹50 Cr | ₹49 Cr | ₹37 Cr | ₹20 Cr |
What is the latest Operating Profit of NATH BIOGENES (INDIA) ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹50 Cr |
| Mar2023 | ₹49 Cr |
| Mar2022 | ₹37 Cr |
| Mar2013 | ₹20 Cr |
How is Operating Profit of NATH BIOGENES (INDIA) Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹50 Cr | 0.02 | |
| Mar2024 | ₹50 Cr | 1.99 | |
| Mar2023 | ₹49 Cr | 31.59 | |
| Mar2022 | ₹37 Cr | 87.05 | |
| Mar2013 | ₹20 Cr | - | |
Compare Operating Profit of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹333.3 Cr | 2.6% | -10.5% | -9.1% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,403.7 Cr | -4.8% | -11.2% | -41.9% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,043.3 Cr | -4.4% | -8.5% | -10.9% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,093.4 Cr | 4.9% | 3.4% | 3.6% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,021.0 Cr | -0.5% | NA | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹500.6 Cr | 11.8% | 11.1% | 17.4% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 2.6% |
-10.5% |
-9.1% |
| SENSEX | -2.4% |
-3.7% |
-9.2% |
You may also like the below Video Courses